Lung Therapeutics, Inc., 10% Owner at TFF Pharmaceuticals, Inc. (TFFP), sold 1,050,000 shares at $13.85 ($14.5M) on 2020-12-04, disclosed to the SEC on 2020-12-08.
Open-market sale of $14.5M TFFP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.85 | 500,000 | $6.9M | 47.6% |
| 2 | $13.86 | 250,000 | $3.5M | 23.8% |
| 3 | $13.86 | 300,000 | $4.2M | 28.6% |
| Total | $13.86 avg | 1,050,000 | $14.5M | 100% |